Today the Beasley Allen Law Firm presented the Alcazar Wiregrass Shrine Club in Dothan the third Wii gaming system it will give away during its year long "Wii Give Back!" campaign. The system will be used at the Shriners Hospitals for Children in Greenville, S.C. Last fall, the firm donated two Wii gaming systems to rehabilitation centers in Alabama.
Nearly 200 lawsuits have been filed so far in federal and state courts throughout the country. The litigation involves both individual personal injury suits and consumer class actions filed on behalf of Toyota owners who claim that the value of their vehicles has been battered by concerns about sudden unintended acceleration.
Fentora is a powerful painkiller in the opioid family, similar to morphine, and is approved by the Food and Drug Administration (FDA) for the very limited use for the treatment of breakthrough pain in cancer patients currently on around-the-clock opioid therapy. The active ingredient in Fentora is fentanyl buccal. Fentora comes in the form of a lozenge on a stick, like a lollipop. The lozenge is placed above the rear molar tooth between the upper cheek and gum. Patients sometimes experience a gentle bubbling sensation where the tablet was placed as it dissolves.
Several traffic safety concerns have been triggered in the wake of an accident on a stretch of I-65 in Kentucky that claimed the lives of 11 people - an accident that authorities say is one of the worst traffic accidents in the state's history. The accident occurred when a commercial truck driven by 45-year-old Kenneth Laymon of Alabama left the interstate, plowed through a cable barrier, and struck a van head-on, killing the truck driver and ten people in the van. Two children who were secured in safety seats inside the van survived.
Meet Mark. He is a 40-year-old father of three, former college basketball player, and an opioid addict. In February, Mark began a week-long effort to end his addiction before his wife came home from a trip. He says she is the source of his drug abuse. Not intentionally, but her occasional offerings of the powerful painkillers such as Actiq and Fentora to curb his constant headaches drove him to depend on the drugs. Coming clean, he says, has been emotionally and physically painful. He talks about his withdrawal symptoms and urges others to use caution with the drugs in a series of videos he calls the Actiq Diaries designed to show "the evils of the drug called Actiq."
As most Americans know,Ford and Firestone were involved in the world's largest tire recall in history a few years back. Firestone produced a specially designed 15-inch ATX tire in 1990 which were installed by Ford on Explorers as original equipment. Tragically, the Firestone tires were defective and the Explorer was prone to rollover.
The Food and Drug Administration (FDA) has issued a Class 1 recall on a medical system that is used to determine different types of human blood chemistries and analyze fluids including blood, urine and cerebrospinal fluid because there may be excessive build-up of protein, bacteria and sample tube additives in the instrument's ion selective electrode flow cell which may cause incorrect sodium results. An erroneous test result may lead to improper treatment in patients whose chemistry is being tested, which could lead to serious injury or death.
Teleflex Incorporated has issued an update on a previous recall of all lots of Arrow International, Inc. custom intravenous administration products (IV tubing sets and accessories) and some Arrow arterial embolectomy catheters. According to the Food and Drug Administration (FDA), testing has revealed pinholes in some of the pouches in which the products are packaged. It has been determined that these products do not meet sterility standards, which poses a potential risk for infection that could lead to serious injury or death.
Certain lots of the BD Q-Syte Luer Access Split Septum device and other finished products including kits and trays sold by other companies in which the Q-Syte Luer Access device is a component, are being recalled because they are defective and may cause serious injury for patients, according to a Food and Drug Administration (FDA) announcement. This Class 1 recall affects four products used with other infusion therapy products to administer therapies (such as chemotherapy), blood and fluids into the intravenous (IV) system. A Class 1 recall is the most serious type of recall issued by the FDA and is reserved for products where there is a potential for serious injury or death.
Drug maker Cephalon has settled its patent lawsuit with Barr Pharmaceuticals Inc., agreeing to give Barr a license to sell a generic version of Cephalon's potent painkiller Fentora in 2018, according to the Securities and Exchange Commission. Barr will receive a non-exclusive, royalty-free right to sell the drug one year before Cephalon's patent expires. However, if another generic version of Fentora hits the U.S. market before Barr can launch its brand, Barr can introduce its version even earlier than 2018.
